ANGIODYNAMICS INC (ANGO)
Every FINRA and SEC series the site collects for ANGIODYNAMICS INC: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus.
1.4M
Short interest
settlement 2026-08-31
5.4
Days to cover
+0.7% vs prior
15.1%
Short share of volume
2026-09-17
992
Fails to deliver
settlement 2026-08-25
Thu 1 Oct
Next earnings
estimated; last year 2025-10-02
-$344K
Insider flow, 90 days
0 buys, 1 sells
As of 2026-09-17.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 31 August 2026, short interest in ANGO is 1,363,549 shares, up 141,712 shares over the last month. Over the last 48 readings it ranged from 822,906 shares (15 January 2025) to 3,673,538 shares (31 July 2025). At the reported average volume of 252K shares a day that is 5.4 days to cover, elevated.
Embed this chartkeeps the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/ango" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-31 | 1,363,549 | +0.7% | 252,467 | 5.40 |
| 2026-08-14 | 1,353,475 | +10.8% | 552,547 | 2.45 |
| 2026-07-31 | 1,221,837 | -7.1% | 485,094 | 2.52 |
| 2026-07-15 | 1,315,694 | -3.1% | 592,146 | 2.22 |
| 2026-06-30 | 1,357,466 | -22.7% | 469,575 | 2.89 |
| 2026-06-15 | 1,756,552 | -7.0% | 288,475 | 6.09 |
| 2026-05-29 | 1,888,850 | -3.2% | 310,669 | 6.08 |
| 2026-05-15 | 1,951,936 | -5.7% | 278,529 | 7.01 |
| 2026-04-30 | 2,070,280 | -4.2% | 353,193 | 5.86 |
| 2026-04-15 | 2,161,213 | +18.6% | 661,671 | 3.27 |
| 2026-03-31 | 1,821,431 | +2.1% | 424,441 | 4.29 |
| 2026-03-13 | 1,784,550 | -18.0% | 282,420 | 6.32 |
| 2026-02-27 | 2,176,310 | +28.1% | 276,482 | 7.87 |
| 2026-02-13 | 1,699,336 | -17.6% | 449,317 | 3.78 |
| 2026-01-30 | 2,062,441 | -0.1% | 494,650 | 4.17 |
| 2026-01-15 | 2,065,589 | +9.2% | 1,281,413 | 1.61 |
| 2025-12-31 | 1,891,199 | -10.8% | 368,227 | 5.14 |
| 2025-12-15 | 2,121,460 | -0.5% | 428,150 | 4.95 |
| 2025-11-28 | 2,131,334 | -2.0% | 493,127 | 4.32 |
| 2025-11-14 | 2,174,768 | -12.9% | 460,058 | 4.73 |
| 2025-10-31 | 2,496,225 | -11.1% | 459,512 | 5.43 |
| 2025-10-15 | 2,807,680 | +3.7% | 822,817 | 3.41 |
| 2025-09-30 | 2,706,505 | -16.0% | 344,949 | 7.85 |
| 2025-09-15 | 3,221,885 | +7.3% | 411,167 | 7.84 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 17 September 2026, the short share of ANGO volume is 15.1%, down 32.1 points over the last five sessions. Over the last 52 readings it ranged from 15.1% (17 September 2026) to 57.6% (27 August 2026). The latest reading sits at the bottom of that range. The latest reading is 22.0 points below the 30-session average of 37.0%, on 250K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-17 | 38K | 250K | 15.1% | 0 |
| 2026-09-16 | 31K | 171K | 17.9% | 0 |
| 2026-09-15 | 57K | 332K | 17.1% | 0 |
| 2026-09-14 | 41K | 115K | 35.3% | 0 |
| 2026-09-11 | 37K | 101K | 36.6% | 0 |
| 2026-09-10 | 34K | 71K | 47.1% | 12 |
| 2026-09-09 | 48K | 94K | 51.5% | 0 |
| 2026-09-08 | 45K | 131K | 34.7% | 0 |
| 2026-09-04 | 35K | 201K | 17.3% | 0 |
| 2026-09-03 | 40K | 141K | 28.7% | 519 |
| 2026-09-02 | 35K | 111K | 31.7% | 0 |
| 2026-09-01 | 25K | 62K | 39.6% | 56 |
| 2026-08-31 | 48K | 122K | 39.5% | 0 |
| 2026-08-28 | 23K | 61K | 38.0% | 0 |
| 2026-08-27 | 52K | 91K | 57.6% | 0 |
| 2026-08-26 | 29K | 65K | 44.1% | 0 |
| 2026-08-25 | 40K | 75K | 53.2% | 0 |
| 2026-08-24 | 21K | 43K | 47.8% | 0 |
| 2026-08-21 | 18K | 58K | 30.9% | 15 |
| 2026-08-20 | 28K | 52K | 52.8% | 40 |
| 2026-08-19 | 34K | 88K | 38.8% | 0 |
| 2026-08-18 | 31K | 68K | 45.2% | 0 |
| 2026-08-17 | 32K | 73K | 43.8% | 0 |
| 2026-08-14 | 27K | 88K | 30.4% | 0 |
| 2026-08-13 | 45K | 133K | 33.4% | 1,500 |
| 2026-08-12 | 73K | 202K | 36.1% | 0 |
| 2026-08-11 | 83K | 254K | 32.9% | 0 |
| 2026-08-10 | 53K | 200K | 26.5% | 0 |
| 2026-08-07 | 57K | 132K | 43.4% | 12 |
| 2026-08-06 | 37K | 83K | 44.6% | 0 |
Fails to deliver
SEC, by settlement date. JSONAs of 25 August 2026, the fails-to-deliver balance in ANGO is 992 shares, up 966 shares over the last settlement date. Over the last 52 readings it ranged from 1 share (11 May 2026) to 76,623 shares (20 April 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-25 | 992 | $15.77 | $16K |
| 2026-08-19 | 26 | $15.82 | $411 |
| 2026-08-18 | 1,363 | $15.67 | $21K |
| 2026-08-17 | 2,288 | $15.85 | $36K |
| 2026-07-31 | 1,548 | $14.77 | $23K |
| 2026-07-21 | 558 | $13.71 | $8K |
| 2026-07-07 | 6 | $12.98 | $78 |
| 2026-06-30 | 32 | $13.20 | $422 |
| 2026-06-24 | 771 | $12.37 | $10K |
| 2026-06-22 | 1,151 | $12.15 | $14K |
| 2026-06-15 | 79 | $12.10 | $956 |
| 2026-06-12 | 451 | $12.08 | $5K |
| 2026-06-10 | 234 | $12.34 | $3K |
| 2026-06-09 | 1 | $11.93 | $12 |
| 2026-06-08 | 1 | $11.94 | $12 |
| 2026-06-04 | 1 | $11.20 | $11 |
| 2026-06-03 | 269 | $10.98 | $3K |
| 2026-05-26 | 127 | $11.92 | $2K |
| 2026-05-18 | 934 | $10.77 | $10K |
| 2026-05-11 | 1 | $11.20 | $11 |
| 2026-04-20 | 76,623 | $10.86 | $832K |
| 2026-04-01 | 72 | $11.37 | $819 |
| 2026-03-23 | 740 | $10.41 | $8K |
| 2026-03-20 | 3,453 | $10.63 | $37K |
| 2026-03-05 | 160 | $10.99 | $2K |
| 2026-03-04 | 120 | $11.04 | $1K |
| 2026-03-03 | 382 | $11.36 | $4K |
| 2026-02-25 | 1,382 | $11.43 | $16K |
| 2026-02-19 | 100 | $11.13 | $1K |
| 2026-02-06 | 503 | $10.06 | $5K |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at ANGO reported 1 open-market sell worth $344K in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Nighan Warren JR (SVP Quality and Regulatory) on 2026-07-30.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-07-30 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 23K | $14.72 | $344K | 65K |
| 2026-07-22 | Piccinini Laura | SVP International | Tax withholding | 5K | $13.82 | $62K | 82K |
| 2026-07-22 | Piccinini Laura | SVP International | Option exercise | 8K | $0.00 | $0 | 86K |
| 2026-07-22 | Nighan Warren JR | SVP Quality and Regulatory | Tax withholding | 2K | $13.82 | $23K | 88K |
| 2026-07-22 | Nighan Warren JR | SVP Quality and Regulatory | Option exercise | 6K | $0.00 | $0 | 90K |
| 2026-07-22 | Trowbridge Stephen A | EVP and CFO | Tax withholding | 8K | $13.82 | $115K | 306K |
| 2026-07-22 | Trowbridge Stephen A | EVP and CFO | Option exercise | 16K | $0.00 | $0 | 314K |
| 2026-07-22 | Clemmer James C | President and CEO | Tax withholding | 27K | $13.82 | $369K | 862K |
| 2026-07-22 | Clemmer James C | President and CEO | Option exercise | 52K | $0.00 | $0 | 889K |
| 2026-07-22 | Campbell Chad Thomas | SVP/GM, Vascular Access | Tax withholding | 2K | $13.82 | $32K | 109K |
| 2026-07-22 | Campbell Chad Thomas | SVP/GM, Vascular Access | Option exercise | 6K | $0.00 | $0 | 111K |
| 2026-07-20 | Trowbridge Stephen A | EVP and CFO | Tax withholding | 717 | $13.71 | $10K | 245K |
| 2026-07-20 | Piccinini Laura | SVP International | Tax withholding | 616 | $13.71 | $8K | 59K |
| 2026-07-20 | Nighan Warren JR | SVP Quality and Regulatory | Tax withholding | 251 | $13.71 | $3K | 66K |
| 2026-07-20 | Clemmer James C | President and CEO | Tax withholding | 4K | $13.71 | $58K | 837K |
| 2026-07-20 | Campbell Chad Thomas | SVP/GM, Vascular Access | Tax withholding | 359 | $13.71 | $5K | 88K |
| 2026-07-19 | Clemmer James C | President and CEO | Tax withholding | 487 | $13.51 | $7K | 841K |
| 2026-07-19 | Clemmer James C | President and CEO | Tax withholding | 12K | $13.51 | $159K | 842K |
| 2026-07-17 | Trowbridge Stephen A | EVP and CFO | Tax withholding | 4K | $13.51 | $47K | 245K |
| 2026-07-17 | Piccinini Laura | SVP International | Tax withholding | 3K | $13.51 | $42K | 59K |
| 2026-07-17 | Nighan Warren JR | SVP Quality and Regulatory | Tax withholding | 1K | $13.51 | $19K | 66K |
| 2026-07-17 | Clemmer James C | President and CEO | Tax withholding | 11K | $13.51 | $144K | 853K |
| 2026-07-17 | Campbell Chad Thomas | SVP/GM, Vascular Access | Tax withholding | 1K | $13.51 | $15K | 89K |
| 2026-07-16 | Weiss Lawrence T | SVP, Chief Legal Officer | Tax withholding | 2K | $14.14 | $32K | 91K |
| 2026-07-16 | Trowbridge Stephen A | EVP and CFO | Tax withholding | 8K | $14.14 | $111K | 249K |
| 2026-07-16 | Piccinini Laura | SVP International | Tax withholding | 5K | $14.14 | $64K | 62K |
| 2026-07-16 | Nighan Warren JR | SVP Quality and Regulatory | Tax withholding | 2K | $14.14 | $30K | 68K |
| 2026-07-16 | Clemmer James C | President and CEO | Tax withholding | 19K | $14.14 | $263K | 864K |
| 2026-07-16 | Campbell Chad Thomas | SVP/GM, Vascular Access | Tax withholding | 2K | $14.14 | $33K | 90K |
| 2026-07-15 | REED JAN STERN | n/a | Grant | 12K | $0.00 | $0 | 117K |
| 2026-07-15 | Licitra Karen A | n/a | Grant | 12K | $0.00 | $0 | 102K |
| 2026-07-15 | JOHNSON WESLEY | n/a | Grant | 12K | $0.00 | $0 | 155K |
| 2026-07-15 | DONNELLY HOWARD W | n/a | Grant | 12K | $0.00 | $0 | 179K |
| 2026-07-15 | Burgess Lorinda | n/a | Grant | 12K | $0.00 | $0 | 67K |
| 2026-07-15 | Auen Eileen O'Shea | n/a | Grant | 12K | $0.00 | $0 | 117K |
| 2026-07-15 | Tarnoff Michael E | n/a | Grant | 12K | $0.00 | $0 | 95K |
| 2026-07-15 | Trowbridge Stephen A | EVP and CFO | Grant | 53K | $0.00 | $0 | 298K |
| 2026-07-15 | Piccinini Laura | SVP International | Grant | 20K | $0.00 | $0 | 78K |
| 2026-07-15 | Nighan Warren JR | SVP Quality and Regulatory | Grant | 18K | $0.00 | $0 | 84K |
| 2026-07-15 | Campbell Chad Thomas | SVP/GM, Vascular Access | Grant | 16K | $0.00 | $0 | 105K |
| 2026-07-15 | Weiss Lawrence T | SVP, Chief Legal Officer | Grant | 21K | $0.00 | $0 | 113K |
| 2025-10-21 | Weiss Lawrence T | SVP, Chief Legal Officer | Buy | 10K | $11.81 | $118K | 94K |
| 2025-10-13 | Trowbridge Stephen A | EVP and CFO | Buy | 890 | $11.16 | $10K | 257K |
| 2025-10-09 | Clemmer James C | President and CEO | Buy | 10K | $11.15 | $112K | 883K |
| 2025-07-21 | Trowbridge Stephen A | EVP and CFO | Tax withholding | 667 | $8.99 | $6K | 256K |
| 2025-07-21 | Nighan Warren JR | SVP Quality and Regulatory | Tax withholding | 277 | $8.99 | $2K | 70K |
| 2025-07-21 | Campbell Chad Thomas | SVP/GM, Vascular Access | Tax withholding | 395 | $8.99 | $4K | 92K |
| 2025-07-20 | Trowbridge Stephen A | EVP and CFO | Tax withholding | 717 | $8.69 | $6K | 256K |
| 2025-07-20 | Piccinini Laura | SVP International | Tax withholding | 616 | $8.69 | $5K | 67K |
| 2025-07-20 | Nighan Warren JR | SVP Quality and Regulatory | Tax withholding | 251 | $8.69 | $2K | 70K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Planned sales (Form 144)
Newest first. JSON1 Form 144 notice on file for ANGO worth $344K at the prices reported; 1 in the last 90 days worth $344K. Latest: WARREN NIGHAN filed on 2026-07-30 to sell 23,370 shares ($344K) from 2026-07-30.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-07-30 | WARREN NIGHANOfficer | 23K | $344K | 0.057% | 2026-07-30 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person, newest filing first. JSON15 holders above 5% have filed on ANGO, all on Schedule 13G (passive). The largest reported stake is Steven A. Cohen at 7.7% of the class (3,181,829 shares), filed 2026-05-15 for an event on 2026-03-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-05-15 | 13G/Ano. 2 | Steven A. Cohenindividual | 3.2M | 7.7% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | Point72 Capital Advisors, Inc.corporation | 3.2M | 7.7% | 2026-03-31 |
| 2026-05-15 | 13G/Ano. 2 | Point72 Asset Management, L.P.partnership | 3.2M | 7.7% | 2026-03-31 |
| 2026-03-26 | 13G/Ano. 7 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
| 2026-02-13 | 13G/Ano. 2 | Divisadero Street Capital Management, LPinvestment adviser, partnership | 5K | 0.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 2 | William Zolezziparent holding company, individual | 5K | 0.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 2 | Divisadero Street Partners, L.P.partnership | 4K | 0.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 2 | Divisadero Street Partners GP, LLCparent holding company, other entity | 4K | 0.0% | 2025-12-31 |
| 2026-02-13 | 13G/Ano. 2 | Divisadero Street Capital, LLCparent holding company, other entity | 5K | 0.0% | 2025-12-31 |
| 2026-02-10 | 13G | SYSTEMATIC FINANCIAL MANAGEMENT LPinvestment adviser | 2.5M | 6.1% | 2025-12-31 |
| 2026-02-09 | 13G | KEVIN KOTLERindividual | 2.4M | 5.9% | 2026-01-06 |
| 2026-01-08 | 13G/Ano. 1 | Israel A. Englanderindividual | 843K | 2.0% | 2025-12-31 |
| 2026-01-08 | 13G/Ano. 1 | Millennium Management LLCother entity | 843K | 2.0% | 2025-12-31 |
| 2026-01-08 | 13G/Ano. 1 | Millennium Group Management LLCother entity | 843K | 2.0% | 2025-12-31 |
| 2026-01-08 | 13G/Ano. 1 | Integrated Core Strategies (US) LLCother entity | 552K | 1.3% | 2025-12-31 |
| 2025-11-14 | 13G/Ano. 1 | Point72 Capital Advisors, Inc.corporation | 2.6M | 6.2% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Steven A. Cohenindividual | 2.6M | 6.2% | 2025-09-30 |
| 2025-11-14 | 13G/Ano. 1 | Point72 Asset Management, L.P.partnership | 2.6M | 6.2% | 2025-09-30 |
13F holders
Tracked managers holding ANGO at their latest 13F. JSON6 of the 30 tracked managers held ANGO at their latest 13F, $71.4M in total at quarter-end prices. Point72 Asset Management is the largest at $39.8M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 3 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Point72 Asset Management | 2026-06-30 | 3.1M | $39.8M | 0.04% | -119K |
| Millennium Management | 2026-06-30 | 783K | $10.2M | 0.00% | new or n/a |
| Renaissance Technologies | 2026-06-30 | 734K | $9.5M | 0.01% | -69K |
| AQR Capital Management | 2026-06-30 | 589K | $7.7M | 0.00% | +338K |
| Two Sigma Investments | 2026-06-30 | 306K | $4.0M | 0.00% | +76K |
| Citadel Advisors | 2026-06-30 | 12K | $162K | 0.00% | -53K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q4 2025 (quarter ended 2026-05-31) ANGIODYNAMICS INC reported revenue of $86.6M, up 18.9% from the same quarter a year earlier, and net loss of $11.4M. In FY 2025 it generated $3.1M of operating cash flow.
- Cash
- $53.9M
- Equity
- $170.8M
- Total assets
- $267.2M
- Shares outstanding
- 41,332,389
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q4 2025derived | 2026-05-31 | $86.6M | -$11.4M | -13.2% | n/a |
| Q1 2026 | 2026-02-28 | $78.4M | -$8.1M | -10.3% | -0.19 |
| Q4 2025 | 2025-11-30 | $79.4M | -$6.3M | -8.0% | -0.15 |
| Q3 2025 | 2025-08-31 | $75.7M | -$10.9M | -14.4% | -0.26 |
| Q4 2024derived | 2025-05-31 | $80.2M | -$6.0M | -7.5% | n/a |
| Q1 2025 | 2025-02-28 | $72.0M | -$4.4M | -6.1% | -0.11 |
| Q4 2024 | 2024-11-30 | $72.8M | -$10.7M | -14.7% | -0.26 |
| Q3 2024 | 2024-08-31 | $67.5M | -$12.8M | -19.0% | -0.31 |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2026-05-31 | $320.2M | -$36.7M | $3.1M | $2.6M | $0 | n/a |
| FY 2024 | 2025-05-31 | $292.5M | -$34.0M | -$10.1M | $4.5M | $1.7M | n/a |
| FY 2023 | 2024-05-31 | $303.9M | -$184.3M | -$28.2M | $2.5M | $0 | n/a |
| FY 2022 | 2023-05-31 | $338.8M | -$52.4M | $78K | $3.8M | $0 | n/a |
| FY 2021 | 2022-05-31 | $316.2M | -$26.5M | -$7.2M | $4.3M | n/a | n/a |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are cash paid to repurchase common stock in the year (XBRL PaymentsForRepurchaseOfCommonStock), not authorizations. Balance sheet lines are as of 2026-05-31; shares outstanding as of 2026-07-10 from the cover page.
What this page is
ANGIODYNAMICS INC in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows ANGIODYNAMICS INC (ANGO), SEC CIK 1275187, listed on Nasdaq, classified by the SEC as surgical & medical instruments & apparatus. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-31.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-17.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-25.JSON and CSV
- Planned sales
- SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-07-30.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-05-15.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC XBRL company factsRefreshed weekly from the SEC's structured data; values are as filed in the 10-Q and 10-K. Latest 2026-05-31.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K Item 2.02 (full-text search)EDGAR full-text search read twice a day; the estimate is last year's date plus 52 weeks. Latest 2026-07-14.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-07-30.JSON and CSV
- Company record
- EDGAR filing index for CIK 1275187Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 18 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as surgical & medical instruments & apparatus
- BSXBOSTON SCIENTIFIC CORP
- TNDMTANDEM DIABETES CARE INC
- DXCMDEXCOM INC
- PENPenumbra Inc
- SIBNSI-BONE, Inc.
- MMM3M CO
- LMATLEMAITRE VASCULAR INC
- INSPInspire Medical Systems, Inc.
- NVCRNovoCure Ltd
- RMDRESMED INC
- SYKSTRYKER CORP
- GKOSGLAUKOS Corp
- IRTCiRhythm Holdings, Inc.
- ICUIICU MEDICAL INC/DE
- ATECAlphatec Holdings, Inc.
- AORTARTIVION, INC.
- PODDINSULET CORP
- BDXBECTON DICKINSON & CO
- IRMDIRADIMED CORP
- ATRCAtriCure, Inc.
- UFPTUFP TECHNOLOGIES INC
- LUNGPulmonx Corp
- MMSIMERIT MEDICAL SYSTEMS INC
- OFIXOrthofix Medical Inc.
Datasets
Frequently Asked Questions
How much of ANGO is sold short?
What is ANGO's daily short volume?
Does ANGO have fails to deliver?
Are ANGO insiders buying or selling?
Have ANGO insiders filed to sell?
Who owns more than 5% of ANGO?
What did ANGO report last quarter?
Which funds hold ANGO?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.